Table 1.
Baseline Characteristics of 187 Cases Treated for a Cutibacterium PJI With (n = 81, 43.3%) and Without (n = 106, 56.7%) a Rifampin Combination
| All Patients | With Rifampin | Without Rifampin | Comparison (P Value) | ||
|---|---|---|---|---|---|
| Total | 187 | 81 | 106 | ||
| General patient information | |||||
| Follow-up time | Months (median, IQR) | 36 [23, 60] | 43 [25, 70] | 33 [21, 47] | .0344 |
| Sex | Male | 135/187 (72.2%) | 60/81 (74.1%) | 75/106 (70.8%) | .7359 |
| Female | 52/187 (27.8%) | 21/81 (25.9%) | 31/106 (29.2%) | ||
| Age | Median, IQR | 67 [58, 74] | 65 [57, 72] | 68 [59, 76] | .1959 |
| Body mass index | Median, IQR | 28 [26, 32] | 28 [25, 30] | 29 [27, 32] | .2525 |
| Country | Country 1 | 105/187 (56.1%) | 62/81 (76.5%) | 43/106 (40.6%) | .0002 |
| Country 2 | 28/187 (15.0%) | 10/81 (12.3%) | 18/106 (17.0%) | ||
| Country 3 | 19/187 (10.2%) | 4/81 (4.9%) | 15/106 (14.2%) | ||
| Country 4 | 13/187 (7.0%) | 0/81(0.0%) | 13/106 (12.3%) | ||
| Country 5 | 7/187 (3.7%) | 1/81 (1.2%) | 6/106 (5.7%) | ||
| Country 6 | 7/187 (3.7%) | 2/81 (2.5%) | 5/106 (4.7%) | ||
| Country 7 | 6/187 (3.2%) | 2/81 (2.5%) | 4/106 (3.8%) | ||
| Country 8 | 1/187 (0.5%) | 0/81 (0.0%) | 1/106 (0.9%) | ||
| Country 9 | 1/187 (0.5%) | 0/81 (0.0%) | 1/106 (0.9%) | ||
| Prosthesis | |||||
| Joint prosthesis | Hip | 97/187 (51.9%) | 40/81 (49.4%) | 57/106 (53.8%) | .3501 |
| Shoulder | 70/187 (37.4%) | 34/81 (42.0%) | 36/106 (34.0%) | ||
| Knee | 17/187 (9.1%) | 7/81 (8.6%) | 10/106 (9.4%) | ||
| Other (foot, elbow) | 3/187 (1.6%) | 0/81 (0.0%) | 3/106 (2.8%) |
Body mass index was defined as the weight (in kg) divided by the height (in m) squared.